2 completed, 1 terminated. 2 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Terminated 1 |
| Phase 2 | 1 | Completed 1 |
Follow Gynecological Laparoscopic Surgery: new trials by email Literature Review of Gynecological Laparoscopic Surgery trials Research Report on Gynecological Laparoscopic Surgery
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Midazolam Adjunct Therapy for Prevention of PONV in Gynecological Laparoscopy Midazolam 0.05 mg/kg IV as adjunct to dexamethasone and ondansetron for PONV prevention - Postoperative Nausea and Vomiting (PONV), Gynecological Laparoscopic Surgery | Phase 2 | Completed | Hameed Latif Hospital, Lahore | 300 | 2025-12-02 | 2026-06-25 |
| Effects and Safety of Oliceridine in Anesthesia Induction:A Randomised Controlled Trial Oliceridine, Sufentanil - Gynecological Laparoscopic Surgery, General Anesthetic | Not applicable | Completed | Tangshan Maternal and Child Health Hospital | 120 | 2025-10-01 | 2026-01-28 |
| Study Designed to Assess the Safety and Feasibility of the Levita Magnetic Surgical System in Laparoscopic Gynecological Procedures Surgical System - Gynecological Laparoscopic Surgery | Not applicable | Terminated | Levita Magnetics | 12 | 2024-12-30 | 2026-02-27 |
Postoperative Nausea and Vomiting (1)
Nausea (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Postoperative Complications (1) · Signs and Symptoms (1) · Signs and Symptoms, Digestive (1) · Vomiting (1)
((3-methoxythiophen-2-yl)methyl)((2-(9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine (1) · Midazolam (1) · Ondansetron (1) · Saline Solution (1) · Sufentanil (1)
Hameed Latif Hospital, Lahore (1) · Levita Magnetics (1) · Tangshan Maternal and Child Health Hospital (1)
Chile (1) · China (1) · Pakistan (1)